Results 111 to 120 of about 18,555 (176)

Mechanistic analysis of luteolin in mitigating dry age-related macular degeneration through network pharmacology and experimental validation. [PDF]

Sci Rep
Luo M, Zhang M, Xing Z, Yu W, Lv H.
europepmc   +1 more source

A Response to: Letter to the Editor Regarding "Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration". [PDF]

Ophthalmol Ther
Borrelli E, Coco G, Scorcia V, Carnevali A, Reibaldi M, Giannaccare G.   +5 more
europepmc   +1 more source

Radiomic Characterization and Automated Classification of Drusen Substructure Phenotype Associated with High-Risk Dry Age-Related Macular Degeneration. [PDF]

Diagnostics (Basel)
Perkins SW, Shah N, Whitney J, Matar K, Yu HJ, Wykoff CC, Ehlers JP.   +6 more
europepmc   +1 more source

Safety and tolerability of RPESC-RPE transplantation in patients with dry age-related macular degeneration: Low-dose clinical outcomes. [PDF]

Cell Stem Cell
Rao RC, Arduini BL, Borden S, Sareen D, Svendsen C, Lee P, Ryan C, Kodati S, Nyaiburi C, Wolsieffer K, Oh E, Park S, Ford G, Dionne K, Temple S, Stern J.   +15 more
europepmc   +1 more source

Intravitreal Administration of Avacincaptad Pegol in a Nonhuman Primate Model of Dry Age-Related Macular Degeneration. [PDF]

Pharmacol Res Perspect
Fujii R, Matsushita M, Itani Y, Hama A, Natsume T, Takamatsu H.   +5 more
europepmc   +1 more source

Progress in the Treatment of Dry Age-Related Macular Degeneration

Advances in Clinical Medicine, 2020
openaire   +1 more source

Single-cell RNA sequencing highlights a significant retinal Müller glial population in dry age-related macular degeneration. [PDF]

iScience
Zeng B, Zhang C, Liang Y, Huang J, Li D, Liu Z, Liao H, Yang T, Liu M, Zou C, Liu D, Qin B.   +11 more
europepmc   +1 more source

Adaptive Optics-Transscleral Flood Illumination Imaging of Retinal Pigment Epithelium in Dry Age-Related Macular Degeneration. [PDF]

Cells
Kowalczuk L, Dornier R, Navarro A, Jeunet F, Moser C, Behar-Cohen F, Mantel I.   +6 more
europepmc   +1 more source

Clinical Outcomes of an Enhanced and Conventional Monofocal IOL in Patients with Early and Intermediate Dry Age-Related Macular Degeneration. [PDF]

Clin Ophthalmol
Venter JA, Berry CW, Hannan NC, Raju D, Kiss HJ, Belovari M, Hannan SJ, Cooper DR, Schallhorn JM.   +8 more
europepmc   +1 more source

In Vivo Characterization of ONL1204, a Small Peptide Inhibitor of the Fas Receptor, as a Potential Neuroprotective Therapy for Geographic Atrophy and Dry Age-Related Macular Degeneration. [PDF]

Biomedicines
Kocab AJ, Cano M, Bacellar-Galdino M, Jamison JA, Brock WJ, Zacks DN, Handa JT.   +6 more
europepmc   +1 more source